3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
45
Breast Neoplasms
20
Myelodysplastic Syndromes
19
Prostatic Neoplasms
12
Neoplasms
12
Leukemia, Myelomonocytic, Chronic
12
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Recurrence
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Uterine Cervical Neoplasms
6
Sarcoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Esophageal Neoplasms
6
Myeloproliferative Disorders
5
Melanoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Lung Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Biphenotypic, Acute
4
Leukemia
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Cholangiocarcinoma
4
Interventions
Radiosurgery
113
Temozolomide
104
Bevacizumab
70
Radiotherapy
66
Magnetic Resonance Spectroscopy
66
Carboplatin
29
pembrolizumab
27
Irinotecan
26
Surgical Procedures, Operative
25
Nivolumab
23
Radiation
22
Etoposide
22
Magnetic Resonance Imaging
21
Ipilimumab
21
Erlotinib Hydrochloride
21
Cyclophosphamide
21
Surveys and Questionnaires
19
Aminolevulinic Acid
18
Specimen Handling
16
Pemetrexed
16
Mental Status and Dementia Tests
16
Cisplatin
16
Carmustine
15
Topotecan
14
Trastuzumab
13
Saline Solution
12
Neuropsychological Tests
12
Gefitinib
11
Filgrastim
11
Drug Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Brain Neoplasms
×
Injections
×
Clear all
NCT02584400
2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2
Terminated
1 enrolled